Post-Translational Modifications of the P2X4 Purinergic Receptor Subtype in the Human Placenta are Altered in Preeclampsia

V. H J Roberts, R. P. Webster, D. E. Brockman, B. A. Pitzer, L. Myatt

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

P2X4 receptors are activated by extracellular ATP to raise intracellular calcium, thus altering cell signalling. ATP release occurs under pathophysiological, stress and adverse cell conditions; these are all increased in preeclampsia. Although P2X4 is abundantly expressed in normal placenta neither the differences in the amount of protein nor its post-translational modifications have been studied in placentae from pregnancies complicated by preeclampsia. Thus we examined P2X4 protein expression, localization and post-translational modifications in normotensive controls, term and preterm preeclamptic placentae. Densitometric analysis of Western blots showed a significant increase in P2X4 protein expression in both term (p = 0.002) and preterm preeclamptic (p = 0.0008) placental samples compared to normotensive controls however the tissue localization of this receptor subtype was unaltered across the groups. Our data showed that P2X4 is a nitrated protein in the placenta and this nitration is upregulated in preterm preeclamptic placenta compared to normotensive controls (p = 0.03). We also demonstrated that P2X4 is heavily glycosylated in the placenta by deglycosylation with PNGase F which reduced the protein product size by 23 kDa. We propose that P2X4 acts within the syncytiotrophoblast to alter intracellular calcium and subsequent signalling pathways thereby restoring placental cell homeostasis following ATP-induced changes during pathophysiological conditions such as preeclampsia. We also propose that the post-translational modifications of nitration and glycosylation are required for the normal functioning of P2X4.

Original languageEnglish (US)
Pages (from-to)270-277
Number of pages8
JournalPlacenta
Volume28
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Purinergic P2X4 Receptors
Post Translational Protein Processing
Pre-Eclampsia
Placenta
Adenosine Triphosphate
Proteins
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
Calcium Signaling
Trophoblasts
Glycosylation
Homeostasis
Western Blotting
Calcium
Pregnancy

Keywords

  • Glycosylation
  • Nitration
  • Placenta
  • Preeclampsia
  • Purinergic

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Post-Translational Modifications of the P2X4 Purinergic Receptor Subtype in the Human Placenta are Altered in Preeclampsia. / Roberts, V. H J; Webster, R. P.; Brockman, D. E.; Pitzer, B. A.; Myatt, L.

In: Placenta, Vol. 28, No. 4, 04.2007, p. 270-277.

Research output: Contribution to journalArticle

Roberts, V. H J ; Webster, R. P. ; Brockman, D. E. ; Pitzer, B. A. ; Myatt, L. / Post-Translational Modifications of the P2X4 Purinergic Receptor Subtype in the Human Placenta are Altered in Preeclampsia. In: Placenta. 2007 ; Vol. 28, No. 4. pp. 270-277.
@article{882b34cfd6f747e8a28813f969435c3d,
title = "Post-Translational Modifications of the P2X4 Purinergic Receptor Subtype in the Human Placenta are Altered in Preeclampsia",
abstract = "P2X4 receptors are activated by extracellular ATP to raise intracellular calcium, thus altering cell signalling. ATP release occurs under pathophysiological, stress and adverse cell conditions; these are all increased in preeclampsia. Although P2X4 is abundantly expressed in normal placenta neither the differences in the amount of protein nor its post-translational modifications have been studied in placentae from pregnancies complicated by preeclampsia. Thus we examined P2X4 protein expression, localization and post-translational modifications in normotensive controls, term and preterm preeclamptic placentae. Densitometric analysis of Western blots showed a significant increase in P2X4 protein expression in both term (p = 0.002) and preterm preeclamptic (p = 0.0008) placental samples compared to normotensive controls however the tissue localization of this receptor subtype was unaltered across the groups. Our data showed that P2X4 is a nitrated protein in the placenta and this nitration is upregulated in preterm preeclamptic placenta compared to normotensive controls (p = 0.03). We also demonstrated that P2X4 is heavily glycosylated in the placenta by deglycosylation with PNGase F which reduced the protein product size by 23 kDa. We propose that P2X4 acts within the syncytiotrophoblast to alter intracellular calcium and subsequent signalling pathways thereby restoring placental cell homeostasis following ATP-induced changes during pathophysiological conditions such as preeclampsia. We also propose that the post-translational modifications of nitration and glycosylation are required for the normal functioning of P2X4.",
keywords = "Glycosylation, Nitration, Placenta, Preeclampsia, Purinergic",
author = "Roberts, {V. H J} and Webster, {R. P.} and Brockman, {D. E.} and Pitzer, {B. A.} and L. Myatt",
year = "2007",
month = "4",
doi = "10.1016/j.placenta.2006.04.008",
language = "English (US)",
volume = "28",
pages = "270--277",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Post-Translational Modifications of the P2X4 Purinergic Receptor Subtype in the Human Placenta are Altered in Preeclampsia

AU - Roberts, V. H J

AU - Webster, R. P.

AU - Brockman, D. E.

AU - Pitzer, B. A.

AU - Myatt, L.

PY - 2007/4

Y1 - 2007/4

N2 - P2X4 receptors are activated by extracellular ATP to raise intracellular calcium, thus altering cell signalling. ATP release occurs under pathophysiological, stress and adverse cell conditions; these are all increased in preeclampsia. Although P2X4 is abundantly expressed in normal placenta neither the differences in the amount of protein nor its post-translational modifications have been studied in placentae from pregnancies complicated by preeclampsia. Thus we examined P2X4 protein expression, localization and post-translational modifications in normotensive controls, term and preterm preeclamptic placentae. Densitometric analysis of Western blots showed a significant increase in P2X4 protein expression in both term (p = 0.002) and preterm preeclamptic (p = 0.0008) placental samples compared to normotensive controls however the tissue localization of this receptor subtype was unaltered across the groups. Our data showed that P2X4 is a nitrated protein in the placenta and this nitration is upregulated in preterm preeclamptic placenta compared to normotensive controls (p = 0.03). We also demonstrated that P2X4 is heavily glycosylated in the placenta by deglycosylation with PNGase F which reduced the protein product size by 23 kDa. We propose that P2X4 acts within the syncytiotrophoblast to alter intracellular calcium and subsequent signalling pathways thereby restoring placental cell homeostasis following ATP-induced changes during pathophysiological conditions such as preeclampsia. We also propose that the post-translational modifications of nitration and glycosylation are required for the normal functioning of P2X4.

AB - P2X4 receptors are activated by extracellular ATP to raise intracellular calcium, thus altering cell signalling. ATP release occurs under pathophysiological, stress and adverse cell conditions; these are all increased in preeclampsia. Although P2X4 is abundantly expressed in normal placenta neither the differences in the amount of protein nor its post-translational modifications have been studied in placentae from pregnancies complicated by preeclampsia. Thus we examined P2X4 protein expression, localization and post-translational modifications in normotensive controls, term and preterm preeclamptic placentae. Densitometric analysis of Western blots showed a significant increase in P2X4 protein expression in both term (p = 0.002) and preterm preeclamptic (p = 0.0008) placental samples compared to normotensive controls however the tissue localization of this receptor subtype was unaltered across the groups. Our data showed that P2X4 is a nitrated protein in the placenta and this nitration is upregulated in preterm preeclamptic placenta compared to normotensive controls (p = 0.03). We also demonstrated that P2X4 is heavily glycosylated in the placenta by deglycosylation with PNGase F which reduced the protein product size by 23 kDa. We propose that P2X4 acts within the syncytiotrophoblast to alter intracellular calcium and subsequent signalling pathways thereby restoring placental cell homeostasis following ATP-induced changes during pathophysiological conditions such as preeclampsia. We also propose that the post-translational modifications of nitration and glycosylation are required for the normal functioning of P2X4.

KW - Glycosylation

KW - Nitration

KW - Placenta

KW - Preeclampsia

KW - Purinergic

UR - http://www.scopus.com/inward/record.url?scp=33947714355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947714355&partnerID=8YFLogxK

U2 - 10.1016/j.placenta.2006.04.008

DO - 10.1016/j.placenta.2006.04.008

M3 - Article

VL - 28

SP - 270

EP - 277

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - 4

ER -